- News Releases
-
- Apr. 23, 2021 (PDF/125KB)Finances
- Sumitomo Dainippon Pharma Announces Revisions to Its Financial Forecasts
-
- Apr. 13, 2021 (PDF/81KB)Products
- Urovant Sciences Announces U.S. Commercial Launch of GEMTESA (vibegron) 75 mg Tablets for Patients with Overactive Bladder
-
- Apr. 09, 2021 (PDF/113KB)CSR
- Sumitomo Dainippon Pharma Receives the "Intellectual Property Achievement Awards" for the First Time
Other Notices
-
- Mar. 25, 2021Corporate (PDF/129KB)
- Sumitomo Dainippon Pharma Announces the Launch of Website Dedicated to Frontier Business
-
- Nov. 20, 2020Others
- Posted Factbook 2020 ver.2
-
- Sep. 30, 2020Others
- Posted Integrated Report 2020
IR Library
-
Continuing to challenge ourselves to support a healthy future for people
-
Aiming to create innovative pharmaceutical products
-
Targeting sustainable growth
-
Leading our global expansion